These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10196019)

  • 1. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.
    Benigni A; Zoja C; Noris M; Corna D; Benedetti G; Bruzzi I; Todeschini M; Remuzzi G
    Am J Kidney Dis; 1999 Apr; 33(4):746-53. PubMed ID: 10196019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
    Yatsu T; Sanagi M; Fujimori A; Tomura Y; Hayashi K; Tanahashi M; Inagaki O
    Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery.
    Lozano FS; López-Novoa JM; Rodriguez JM; Barros MB; García-Criado FJ; Nicolás JL; Parreño A; Revilla J; Gómez-Alonso A
    J Vasc Surg; 2005 Jul; 42(1):129-39. PubMed ID: 16012462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the nitric oxide donor molsidomine prevent in warm ischemia-reperfusion injury of the rat renal--a functional and histophatological study.
    Oztürk H; Aldemir M; Büyükbayram H; Dokucu AI; Otçu S
    Int Urol Nephrol; 2001; 32(4):601-7. PubMed ID: 11989549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure.
    Chander V; Chopra K
    Biochim Biophys Acta; 2005 May; 1723(1-3):208-14. PubMed ID: 15777642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
    Yamamoto M; Fukui M; Shou I; Wang LN; Sekizuka K; Suzuki S; Shirato I; Tomino Y
    J Clin Lab Anal; 1997; 11(1):53-62. PubMed ID: 9021525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
    Chander V; Chopra K
    Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction.
    Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Steendijk P; Doevendans PA; Joles JA
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2037-45. PubMed ID: 20852057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats.
    Attia DM; Ni ZN; Boer P; Attia MA; Goldschmeding R; Koomans HA; Vaziri ND; Joles JA
    Kidney Int; 2002 May; 61(5):1776-87. PubMed ID: 11967027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C; Liu XH; Abbate M; Corna D; Schiffrin EL; Remuzzi G; Benigni A
    Exp Nephrol; 1998; 6(2):121-31. PubMed ID: 9567218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
    Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats.
    Rodriguez-Peña A; Garcia-Criado FJ; Eleno N; Arevalo M; Lopez-Novoa JM
    Am J Transplant; 2004 Oct; 4(10):1605-13. PubMed ID: 15367215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats.
    Chander V; Chopra K
    J Surg Res; 2005 Sep; 128(1):132-9. PubMed ID: 15936772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
    Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
    Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.